Karyo Biologics, LLC (KBL) is the second US biosimilars company founded by Sarfaraz K. Niazi to overcome the current hurdles in the approval of biosimilars in the US. Dr. Niazi is highlighted by the Forbes magazine as “the most interesting man revolutionizing the healthcare,” to acknowledge his global efforts to make biosimilars accessible. He has written the largest numbers of books on biosimilars, designed and constructed low-cost, compact biological products manufacturing facilities across the globe. With over 130 US patents, he is the largest solo inventor of biotechnology, new drugs, new dosage forms, testing methods and other patient-related inventions that are widely used across the globe. He is also a licensed practitioner of the patent law at the United States Patent Office, a fellow of several prestigious learned societies, Adjunct professor at four major universities, received the highest civil award of Pakistan, elected Alum of the Year by the University of Illinois and inducted into Entrepreneur Hall of Fame in the USA, having raised the largest amount for any biotech startup. He is currently developing dozens of biosimilars for the US markets.
Conference Keynote Speaker